Cathelicidin (LL-37) vs Temporin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
LL-37 is the sole human cathelicidin antimicrobial peptide, derived by proteolytic cleavage of the 18 kDa precursor hCAP18 (encoded by the CAMP gene). It is produced by neutrophils, epithelial cells of the skin, gut, and airways, and mast cells....
Calculate Cathelicidin (LL-37) dose →Temporins are a family of short (10-14 amino acid) cationic antimicrobial peptides isolated from the skin secretions of the European common frog (Rana temporaria). First described by Simmaco et al....
Calculate Temporin dose →| Parameter | Cathelicidin (LL-37) | Temporin |
|---|---|---|
| Category | Antimicrobial Peptide | Antimicrobial Peptide |
| Research | Clinical Research | Preclinical |
| Half-Life | < 10 min (plasma) | Minutes (plasma) |
| Typical Dose | Research: 1-100 ug/mL (topical) | Research only |
| Frequency | Varies by application | N/A |
| Route | Endogenous; topical/inhalation (research) | Topical, in vitro (research) |
| FDA Status | No approval (clinical trials ongoing) | No approval |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.